Page last updated: 2024-09-03

3-amino-2-hydroxy-4-phenylbutanoic acid and kni 102

3-amino-2-hydroxy-4-phenylbutanoic acid has been researched along with kni 102 in 1 studies

Compound Research Comparison

Studies
(3-amino-2-hydroxy-4-phenylbutanoic acid)
Trials
(3-amino-2-hydroxy-4-phenylbutanoic acid)
Recent Studies (post-2010)
(3-amino-2-hydroxy-4-phenylbutanoic acid)
Studies
(kni 102)
Trials
(kni 102)
Recent Studies (post-2010) (kni 102)
42031000

Protein Interaction Comparison

ProteinTaxonomy3-amino-2-hydroxy-4-phenylbutanoic acid (IC50)kni 102 (IC50)
Protease Human immunodeficiency virus 10.0074

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Akaji, K; Hattori, N; Imai, J; Kisanuki, S; Kiso, Y; Mimoto, T; Tanaka, S1

Other Studies

1 other study(ies) available for 3-amino-2-hydroxy-4-phenylbutanoic acid and kni 102

ArticleYear
KNI-102, a novel tripeptide HIV protease inhibitor containing allophenylnorstatine as a transition-state mimic.
    Chemical & pharmaceutical bulletin, 1991, Volume: 39, Issue:11

    Topics: Amino Acid Sequence; HIV Protease Inhibitors; Molecular Conformation; Molecular Sequence Data; Oligopeptides; Phenylbutyrates

1991